Literature DB >> 35091980

Psychedelic Group Therapy.

Peter Gasser1.   

Abstract

Gatherings in groups are a ubiquitous phenomenon throughout human history. This is true for everyday social tasks as well as for healing and spiritual purposes. In psychotherapy, group treatment started soon after developing psychoanalytic treatment procedures. For psychedelic therapy however, individual treatment guided by one or sometimes even two therapists is the most common and widespread treatment model for clinical research and therapy thus far. Since the foundation of the Swiss Medical Society for Psycholytic Therapy (Schweizerische Ärztegesellschaft für psycholytische Therapie, SÄPT) in 1985 in Switzerland, we however had the opportunity to conduct psychedelic group treatment in specific settings, which the following article describes.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Group psychotherapy; Group therapy; Limited use of scheduled substances; Psychedelic therapy; Psychedelics; Psychedelics assisted therapy

Mesh:

Substances:

Year:  2022        PMID: 35091980     DOI: 10.1007/7854_2021_268

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  4 in total

1.  How important are the common factors in psychotherapy? An update.

Authors:  Bruce E Wampold
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Psychedelic-Assisted Group Therapy: A Systematic Review.

Authors:  Alexander Trope; Brian T Anderson; Andrew R Hooker; Giancarlo Glick; Christopher Stauffer; Joshua D Woolley
Journal:  J Psychoactive Drugs       Date:  2019-04-05

3.  Efficacy of group psychotherapy for anxiety disorders: A systematic review and meta-analysis.

Authors:  Sarah Barkowski; Dominique Schwartze; Bernhard Strauss; Gary M Burlingame; Jenny Rosendahl
Journal:  Psychother Res       Date:  2020-02-24

4.  Acute subjective effects in LSD- and MDMA-assisted psychotherapy.

Authors:  Yasmin Schmid; Peter Gasser; Peter Oehen; Matthias E Liechti
Journal:  J Psychopharmacol       Date:  2020-10-08       Impact factor: 4.153

  4 in total
  2 in total

1.  Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders.

Authors:  Peter Oehen; Peter Gasser
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 4.157

2.  Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Benedikt Pulver; Hannes M Schwelm; Kyla Whitelock; Alexander Stratford; Volker Auwärter; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2022-05-29       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.